Other
topical insulin
topical insulin is an intervention with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_1
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 1Safety & dosage
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Other(2)
Detailed Status
unknown2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 11 (50.0%)
N/A1 (50.0%)
Trials by Status
unknown267%
completed133%
Recent Activity
0 active trials
Showing 3 of 3
unknownnot_applicable
Insulin Iontophoresis Mixed With Oleic Acid Versus Topical Insulin in Patients With Chronic Diabetic Foot Ulcer
NCT05444842
unknownphase_1
Effects of Topical Insulin on Levels of Tear Inflammatory Mediators
NCT04877210
completed
Topical Insulin - Utility and Results in Neurotrophic Keratopathy in Stages 2 and 3
NCT04820010
Clinical Trials (3)
Showing 3 of 3 trials
NCT05444842Not Applicable
Insulin Iontophoresis Mixed With Oleic Acid Versus Topical Insulin in Patients With Chronic Diabetic Foot Ulcer
NCT04877210Phase 1
Effects of Topical Insulin on Levels of Tear Inflammatory Mediators
NCT04820010
Topical Insulin - Utility and Results in Neurotrophic Keratopathy in Stages 2 and 3
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3